Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +3.9K | +1.82% | $0.00 | 218K | Feb 21, 2022 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$81.8K | -1.92K | -0.88% | $42.55 | 216K | Feb 21, 2022 | Direct | |
holding | BSX | Common Stock | 68.2K | Feb 21, 2022 | By 401(k) | F2 | |||||
holding | BSX | Common Stock | 7.43K | Feb 21, 2022 | By Children | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -3.9K | -50% | $0.00 | 3.9K | Feb 21, 2022 | Common Stock | 3.9K | Direct | F1, F4 |
Id | Content |
---|---|
F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F2 | Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. |
F3 | The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose. |
F4 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant. |